Home » MHRA Fee Proposal: Weak US Dollar Means Heftier Burden for US Firms
MHRA Fee Proposal: Weak US Dollar Means Heftier Burden for US Firms
November 13, 2009
As the dollar struggles against the British pound and euro, U.S. devicemakers will be hit harder than European companies by the fiscal 2010 fee schedule
proposed by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
To View This Article:
Subscribe To International Medical Device Regulatory Monitor